Interrogation of individual datasets in Oncomine and TCGA revealed that LBH was highly overexpressed in B-cell acute lymphoblastic leukemia (B-ALL, +37.7-fold; Fig. S1A.xviii), the most common and aggressive leukemia subtype, and in chronic lymphocytic leukemia (CLL, +2.8-fold) (Table S3). Here, LBH is linked to B-cell acute lymphoblastic leukemia.